A conserved protonation-induced switch can trigger "ionic-lock" formation in adrenergic receptors

Journal of Molecular Biology

Volumn 397, Issue 5, 2010, Pages 1339-1349

  Vanni, Stefano ^a   Neri, Marilisa ^a   Tavernelli, Ivano ^a   Rothlisberger, Ursula ^a  

^a EPFL   (Switzerland)

Author keywords

Adrenergic receptor; GPCR; Molecular dynamics; Signal transduction

Indexed keywords

ADRENERGIC RECEPTOR; ALANINE; ASPARTIC ACID; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; G PROTEIN COUPLED RECEPTOR; OPSIN; SERINE;

ACIDITY; ARTICLE; CONTROLLED STUDY; CRYSTAL STRUCTURE; HUMAN; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTON TRANSPORT; SIGNAL TRANSDUCTION;

EID: 77950517052     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2010.01.060     Document Type: Article

References (65)

1. Lundstrom K. Latest development in drug discovery on G protein-coupled receptors. Curr. Protein Pept. Sci. 2006, 7:465-470.
2. Cherezov V., Rosenbaum D.M., Hanson M.A., Rasmussen S.G., Thian F.S., Choi H.J., et al. High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor. Science 2007, 318:1258-1265.
3. Warne T., Serrano-Vega M.J., Baker J.G., Moukhametzianov R., Edwards P.C., Henderson R., et al. Structure of a beta1-adrenergic G-protein-coupled receptor. Nature 2008, 454:486-492.
4. Weis W.I., Kobilka B.K. Structural insights into G-protein-coupled receptor activation. Curr. Opin. Struct. Biol. 2008, 18:734-740.
5. Ballesteros J.A., Jensen A.D., Liapakis G., Rasmussen S.G.F., Shi L., Gether U., Javitch J.A. Activation of the beta(2)-adrenergic receptor involves disruption of an ionic lock between the cytoplasmic ends of transmembrane segments 3 and 6. J. Biol. Chem. 2001, 276:29171-29177.
6. Lei S., Liapakis G., Xu R., Guarnieri F., Ballesteros J.A., Javitch J.A. beta(2) adrenergic receptor activation-modulation of the proline kink in transmembrane 6 by a rotamer toggle switch. J. Biol. Chem. 2002, 277:40989-40996.
7. Shapiro D.A., Kristiansen K., Weiner D.M., Kroeze W.K., Roth B.L. Evidence for a model of agonist-induced activation of 5-hydroxytryptamine 2A serotonin receptors that involves the disruption of a strong ionic interaction between helices 3 and 6. J. Biol. Chem. 2002, 277:11441-11449.
8. Scheer A., Costa T., Fanelli F., De Benedetti P.G., Mhaouty-Kodja S., Abuin L., et al. Mutational analysis of the highly conserved arginine within the Glu/Asp-Arg-Tyr motif of the alfa1b-adrenergic receptor: effects on receptor isomerization and activation. Mol. Pharmacol. 2000, 57:219-231.
9. Barak L.S., Menard L., Ferguson S.S.G., Colapietro A.M., Caron M.G. The conserved seven-transmembrane sequence NP(X)2,3Y of the G-protein-coupled receptor superfamily regulates multiple properties of the beta(2)-adrenergic receptor. Biochemistry 1995, 34:15407-15414.
10. Urizar E., Claeysen S., Deupi X., Govaerts C., Costagliola S., Vassart G., Pardo L. An activation switch in the rhodopsin family of G protein-coupled receptors. J. Biol. Chem. 2005, 280:17135-17141.
11. Vogel R., Mahalingam M., Ludeke S., Huber T., Siebert F., Sakmar T.P. Functional role of the "ionic lock"-an interhelical hydrogen-bond network in family A heptahelical receptors. J. Mol. Biol. 2008, 380:648-655.
12. 2.50 and ERY motif reveals signaling bias of the urotensin II receptor. Mol. Pharmacol. 2008, 74:552-561.
13. Bihoreau C., Monnot C., Davies E., Teutsch B., Bernstein K.E., Corvol P., Clauser E. Mutation of Asp74 of the rat angiotensin II receptor confers changes in antagonist affinities and abolishes G-protein coupling. Proc. Natl Acad. Sci. USA 1993, 90:5133-5137.
14. Baker J.G., Proudman R.G.W., Hawley N.C., Fischer P.M., Hill S.J. Role of key transmembrane residues in agonist and antagonist actions at the two conformations of the human beta(1)-adrenoceptor. Mol. Pharmacol. 2008, 74:1246-1260.
15. Greasley P.J., Fanelli F., Rossier O., Abuin L., Cotecchia S. Mutagenesis and modelling of the alpha(1b)-adrenergic receptor highlight the role of the helix 3/helix 6 interface in receptor activation. Mol. Pharmacol. 2002, 61:1025-1032.
16. Fritze O., Filipek S., Kuksa V., Palczewski K., Hofmann K.P., Ernst O.P. Role of the conserved NPXXY(x)(5,6)F motif in the rhodopsin ground state and during activation. Proc. Natl Acad. Sci. USA 2003, 100:2290-2295.
17. Palczewski K., Kumasaka T., Hori T., Behnke C.A., Motoshima H., Fox B.A., et al. Crystal structure of rhodopsin: a G protein-coupled receptor. Science 2000, 289:739-745.
18. Okada T., Sugihara M., Bondar A.N., Elstner M., Entel P., Buss V. The retinal conformation and its environment in rhodopsin in light of a new 2.2 Å crystal structure. J. Mol. Biol. 2004, 342:571-583.
19. Li J., Edwards P., Burghammer M., Villa C., Schertler G.F.X. Structure of a bovine rhodopsin in a trigonal crystal form. J. Mol. Biol. 2004, 343:1409-1438.
20. Dror R.O., Arlow D.H., Borhani D.W., Jensen M.O., Piana S., Shaw D.E. Identification of two distinct inactive conformations of the beta2-adrenergic receptor reconciles structural and biochemical observations. Proc. Natl Acad. Sci. USA 2009, 106:4689-4694.
21. Vanni S., Neri M., Tavernelli I., Rothlisberger U. Observation of "ionic lock" formation in molecular dynamics simulations of wild-type beta1 and beta2 adrenergic receptors. Biochemistry 2009, 48:4789-4797.
22. Park J.H., Scheerer P., Hofmann K.P., Choe H.W., Ernst O.P. Crystal structure of the ligand-free G-protein-coupled receptor opsin. Nature 2008, 454:183-187.
23. Farrens D.L., Altenbach C., Yang K., Hubbell W.L., Khorana H.G. Requirement of rigid-body motion of transmembrane helices for light activation of rhodopsin. Science 1996, 274:768-770.
24. Altenbach C., Kusnetzow A.K., Ernst O.P., Hofmann K.P., Hubbell W.L. High-resolution distance mapping in rhodopsin reveals the pattern of helix movement due to activation. Proc. Natl Acad. Sci. USA 2008, 105:7439-7444.
25. Schwartz T.W., Frimurer T.M., Holst B., Rosenkilde M.M., Elling C.E. Molecular mechanism of 7TM receptor activation-a global toggle switch model. Annu. Rev. Pharmacol. 2006, 46:481-519.
26. Seifert R., Wenzel-Seifert K. Constitutive activity of G-protein-coupled receptors: cause of disease and common property of wild-type receptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 2002, 366:381-416.
27. Vilardaga J.P., Steinmeyer G.S., Harms G.S., Lohse M.J. Molecular basis of inverse agonism in a G protein-coupled receptor. Nat. Chem. Biol. 2005, 1:25-28.
28. Yao X.J., Parnot C., Deupi X., Ratnala V.R.P., Swaminath G., Farrens D., Kobilka B. Coupling ligand structure to specific conformational switches in the beta(2)-adrenoceptor. Nat. Chem. Biol. 2006, 2:417-422.
29. Zurn A., Zabel U., Vilardaga J.P., Schindelin H., Lohse M.J., Hoffmann C. FRET-analysis of alpha2a-adrenergic receptor activation reveals distinct agonist-specific conformational changes. Mol. Pharmacol. 2009, 75:534-541.
30. Prioleau C., Visiers I., Ebersole B.J., Weinstein H., Sealfon S.C. Conserved helix 7 tyrosine acts as a multistate conformational switch in the 5HT2C receptor-identification of a novel "locked-on" phenotype and double revertant mutations. J. Biol. Chem. 2002, 277:36577-36584.
31. Pardo L., Deupi X., Doelker N., Lopez-Rodriguez M.L., Campillo M. The role of internal water molecules in the structure and function of the rhodopsin family of G protein-coupled receptors. ChemBioChem 2007, 8:19-24.
32. Strader C.D., Sigal I.S., Candelore M.R., Rands E., Hill W.S., Dixon A.F. Conserved aspartic acid residues 79 and 113 of the beta-adrenergic receptor have different roles in receptor function. J. Biol. Chem. 1988, 263:10267-10271.
33. Ceresa B.P., Limbird L.E. Mutation of an aspartate residue highly conserved among G-protein-coupled receptors results in nonreciprocal disruption of alpha2a-adrenergic receptor-G-protein interactions. J. Biol. Chem. 1994, 269:29557-29564.
34. Ahmed M., Muntasir H.A., Hossain M., Ishiguro M., Komiyama T., Muramatsu I., Kurose H. beta-Blockers show inverse agonism to a novel constitutively active mutant of beta(1)-adrenoceptor. J. Pharmacol. Sci. 2006, 102:167-172.
35. Weitz C.J., Nathans J. Rhodopsin activation: effects on the metarhodopsin I-metarhodopsin II equilibrium of neutralization or introduction of charged amino acids within putative transmembrane segments. Biochemistry 1993, 32:14176-141782.
36. Fahmy K., Jager F., Beck M., Zvyaga T.A., Sakmar T.P., Siebert F. Protonation states of membrane-embedded carboxylic-acid groups in rhodopsin and metarhodopsin-II-a Fourier-transform infrared spectroscopy study of site-directed mutants. Proc. Natl Acad. Sci. USA 1993, 90:10206-10210.
37. Rath P., DeCaluwé L.L.J., Bovee-Geurts P.H.M., De Grip W.J., Rothschild K.J. Fourier transform infrared difference spectroscopy of rhodopsin mutants: light activation of rhodopsin causes hydrogen-bonding change in residue aspartic acid-83 during meta II formation. Biochemistry 1993, 32:10277-10282.
38. Parker M.S., Wong Y.Y., Parker S.L. An ion-responsive motif in the second transmembrane segment of rhodopsin-like receptors. Amino Acids 2008, 35:1-15.
39. Man O., Gilad Y., Lancet D. Prediction of the odorant binding site of olfactory receptor proteins by human-mouse comparisons. Protein Sci. 2004, 13:240-254.
40. Azzi M., Charest P.G., Angers S., Rousseau G., Kohout T., Bouvier M., Pineyro G. beta-Arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors. Proc. Natl Acad. Sci. USA 2003, 100:11406-11411.
41. Swaminath G., Deupi X., Lee T.W., Zhu W., Thian F.S., Kobilka T.S., Kobilka B. Probing the beta(2) adrenoceptor binding site with catechol reveals differences in binding and activation by agonists and partial agonists. J. Biol. Chem. 2005, 280:22165-22171.
42. Bhattacharya S., Hall S.E., Li H., Vaidehi N. Ligand-stabilized conformational states of human beta(2) adrenergic receptor: insight into G-protein-coupled receptor activation. Biophys. J. 2008, 94:2027-2042.
43. Barbhaiya H., McClain R., Ijzerman A., Rivkees S.A. Site-directed mutagenesis of the human A1 adenosine receptor: influences of acidic and hydroxy residues in the first four transmembrane domains on ligand binding. Mol. Pharmacol. 1996, 50:1635-1642.
44. Ghanouni P., Schambye H., Seifert R., Lee T.W., Rasmussen S.G.F., Gether U., Kobilka B.K. The effect of pH on beta2 adrenoceptor function. J. Biol. Chem. 2000, 275:3121-3127.
45. Brooks B.R., Brooks C.L., Mackerell A.D., Nillson L., Peterella R.J., Roux B., et al. CHARMM: the biomolecular simulation program. J. Comput. Chem. 2009, 30:1545-1615.
46. Fiser A., Do R.K., Sali A. Modeling of loops in protein structures. Protein Sci. 2000, 9:1753-1773.
47. Marti-Renom M.A., Stuart A.C., Fiser A., Sanchez R., Melo F., Sali A. Comparative protein structure modeling of genes and genomes. Annu. Rev. Biophys. Biomol. Struct. 2000, 29:291-325.
48. Sali A., Blundell T.L. Comparative protein modelling by satisfaction of spatial restraints. J. Mol. Biol. 1993, 234:779-815.
49. Shen M.Y., Sali A. Statistical potential for assessment and prediction of protein structures. Protein Sci. 2006, 15:2507-2524.
50. Zhang L., Hermans J. Hydrophilicity of cavities in proteins. Proteins: Struct., Funct., Genet. 1996, 24:433-438.
51. Rohrig U., Guidoni L., Rothlisberger U. Early steps of the intramolecular signal transduction in rhodopsin explored by molecular dynamics simulations. Biochemistry 2002, 41:10799-10809.
52. Cornell W.D., Cieplak P., Bayly C.I., Gould I.R., Merz K.M., Ferguson D.M., et al. A 2nd generation force-field for the simulation of proteins, nucleic-acids, and organic-molecules. J. Am. Chem. Soc. 1995, 117:5179-5197.
53. Berendsen H.J.C., Postma J.P.M., Vangunsteren W.F., Hermans J. Interaction models for water in relation to protein hydration. Intermol. Forces 1981, 331-342.
54. Bayly C.I., Cieplak P., Cornell W.D., Kollman P.A. A well-behaved electrostatic potential based method using charge restraints for deriving atomic charges-the RESP model. J. Phys. Chem. 1993, 97:10269-10280.
55. Wang J.M., Cieplak P., Kollman P.A. How well does a restrained electrostatic potential (RESP) model perform in calculating conformational energies of organic and biological molecules?. J. Comput. Chem. 2000, 21:1049-1074.
56. Frisch M.J., Trucks G.W., Schlegel H.B., Scuseria G.E., Robb M.A., Cheeseman J.R., et al. Gaussian 03 2004, Gaussian, Inc., Wallingford, CT.
57. Van der Spoel D., Lindahl E., Hess B., Groenhof G., Mark A.E., Berendsen H.J.C. GROMACS: fast, flexible and free. J. Comput. Chem. 2005, 26:1701-1718.
58. Essmann U., Perera L., Berkowitz M.L., Darden T., Lee H., Pedersen L.G. A smooth particle mesh Ewald method. J. Chem. Phys. 1995, 103:8577-8593.
59. Hess B., Bekker H., Berendsen H.J.C., Fraaije J.G.E.M. LINCS: a linear constraint solver for molecular simulations. J. Comput. Chem. 1997, 18:1463-1472.
60. Nose S. An extension of the canonical ensemble molecular-dynamics method. Mol. Phys. 1986, 57:187-191.
61. Hoover W.G. Canonical dynamics-equilibrium phase-space distributions. Phys. Rev. A 1985, 31:1695-1697.
62. Parrinello M., Rahman A. Polymorphic transitions in single-crystals-a new molecular-dynamics method. J. Appl. Phys. 1981, 52:7182-7190.
63. Humphrey W., Dalke A., Schulten K. VMD-Visual Molecular Dynamics. J. Mol. Graphics 1996, 14:33-38.
64. Yang A.S., Gunner M.R., Sampogna R., Sharp K., Honig B. On the calculation of pK(a)s in protein. Proteins: Struct., Funct., Genet. 1993, 15:252-265.
65. a values for protein-ligand complexes. Proteins: Struct., Funct., Genet. 2008, 73:765-783.